Aimei Health Technology Co., Ltd.
Data quality: 67%
Also listed as
AFJKU
Nasdaq
AFJKR
Nasdaq
AFJK
Nasdaq
Financial Services
Holding & Investment Offices
$62.00
▲
$33.00
(113.79%)
Mkt Cap: 379.55 M
Price
$62.00
Mkt Cap
379.55 M
Day Range
$29.21 — $85.00
52-Week Range
$6.75 — $130.37
Volume
465,021
Open $29.21
50D / 200D Avg
$36.52
69.76% above
50D / 200D Avg
$23.86
159.87% above
Quick Summary
Key Takeaways
Earnings declined -93.28% over the past year
P/E of 117.10 — premium valuation
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-93.28%
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-1.14%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.01
Interest CoverageN/A
Valuation
PE (TTM)
117.10
Above sector avg (11.15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Financial Services sector median (2153 peers)
Peer Comparison
vs Financial Services sector median (2153 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 117.1 | 11.1 |
| P/B | — | 1.2 |
| ROE % | — | 9.2 |
| Net Margin % | — | 9.4 |
| Rev Growth 5Y % | — | 5.8 |
| D/E | — | 0.5 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -93.28% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | 3.24 M |
| ROE | N/A | ROA | 7.20% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | -1.14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.01 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -2.75 M | Tangible Book Value | -3.44 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 117.10 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | 379.55 M | Enterprise Value | 379.55 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.08 | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | 171,389.0 | 2.55 M |
| EPS (Diluted) | 0.08 | — |
| Gross Profit | — | — |
| Operating Income | -28,459.0 | -1.06 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | — | — |
| Income Tax | — | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2023 | FY2024 |
|---|---|---|
| Total Assets | 70.47 M | 73.81 M |
| Total Liabilities | 714,841.0 | 1.51 M |
| Shareholders' Equity | -134,124.0 | -1.48 M |
| Total Debt | — | — |
| Cash & Equivalents | — | — |
| Current Assets | 580,717.0 | 30,384.0 |
| Current Liabilities | 24,841.0 | 816,994.0 |
{"event":"ticker_viewed","properties":{"ticker":"AFJK","listing_kind":"stock","pathname":"/stocks/afjk","exchange":"Nasdaq","country":"US"}}